Study details
Enrolling now
Vagus Nerve Stimulation (VNS) as a Treatment for Fibromyalgia Patients
Massachusetts General Hospital
NCT IDNCT06009159ClinicalTrials.gov data as of Apr 2026
Target enrollment
60
Study length
about 2.3 years
Ages
18–80
Locations
1 site in MA
About this study
Researchers are testing whether vagus nerve stimulation can improve pain and related symptoms in people with fibromyalgia. The treatment involves using a device to stimulate the vagus nerve. The trial will last approximately 852 days.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use Transcutaneous Vagus Nerve Stimulation
Primary goalA modified McGill Pain Questionnaire
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low6%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: A modified McGill Pain Questionnaire
Secondary: Blood inflammation marker, Medical Outcomes Study Questionnaire Short Form 36, Medical Outcomes Study Sleep Scale, Multidimensional Fatigue Inventory
Devices
therapeutic
Body systems
Musculoskeletal